PEAK6 Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,500
Closed -$118K 4804
2018
Q1
$118K Buy
+3,500
New +$134K ﹤0.01% 3635
2016
Q1
Sell
-3,000
Closed -$154K 4887
2015
Q4
$154K Hold
3,000
﹤0.01% 3648
2015
Q3
$135K Hold
3,000
﹤0.01% 4095
2015
Q2
$139K Buy
+3,000
New +$131K ﹤0.01% 4033
2014
Q4
Sell
-7,500
Closed -$243K 5020
2014
Q3
$243K Buy
+7,500
New +$251K ﹤0.01% 3132
2014
Q2
Sell
-500
Closed -$14K 4998
2014
Q1
$14K Hold
500
﹤0.01% 4644
2013
Q4
$18K Buy
+500
New +$16.6K ﹤0.01% 4625

Other funds holding PBH

PEAK6 Group's PBH Position: Q2 2018 in Review

PEAK6 Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2018, closing a stake of 3,742 shares — an estimated $126K sold.

PEAK6 Group first reported a position in PBH in Q1 2014 and held it in 2 quarters. The position peaked at $126K in Q1 2018. 237 funds tracked by Wall St. Rank hold PBH as of Q2 2018.

  • PEAK6 Group reported no remaining Prestige Consumer Healthcare position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 3,742 Prestige Consumer Healthcare shares in Q2 2018, an estimated $126K.
  • PEAK6 Group first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 2 quarters.
  • PEAK6 Group's Prestige Consumer Healthcare position peaked at $126K in Q1 2018.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.